My Adrenal Tumors Journey Chapter 3: Six Pages, Five Unanswered | v64otd.com

My Adrenal Tumors Journey Chapter 3: Six Pages, Five Unanswered

SERIES My Adrenal Tumor Journey

Part 3 of the series

A GI visit that dismissed half of what I came in to ask, five blood tests I had to go look up myself to understand, and the imaging gauntlet that's about to fill my October calendar.

Originally published on Substack. Imported to My Ledger as part of the adrenal journey series.

Quick recap for anyone just joining: Chapter 1 covered fifteen years of “unrelated” diagnoses that turned out to share one cause nobody stepped back far enough to see. Chapter 2 covered the diagnosis itself — bilateral adrenal adenomas, 2.7cm on the right and 2.5cm on the left, confirmed by CT on June 23rd, and Cushing’s Syndrome confirmed August 14th, ACTH-independent, with a 24-hour urine cortisol of 221 mcg — about 4.4 times the upper limit of normal. It also covered the multidisciplinary team at UT Southwestern that reviewed my case together, and the six-hour blood pressure and heart rate episode that landed the day after I met my new endocrinologist, like my own body wanted to underline the point.

This chapter is about a different kind of appointment — one with a doctor I’ve actually seen for years, for something else entirely, that ran into the same structural wall the first two chapters were about.

The visit

On September 9th, I saw my GI doctor’s PA at Texas Digestive Disease Consultants. I’ve been his colon surveillance patient for a while; that relationship predates any of this, but could very well be part of the entire health picture. But once Cushing’s entered the picture, I had real GI-adjacent questions that needed a specialist’s judgment, not a Google search — so I did the thing this whole series keeps circling back to: I did my homework in advance so a fifteen-minute visit couldn’t reduce me to fifteen minutes.

I wrote out a six-page briefing before I went. Diagnosis context up front, my current labs attached, and seven numbered sections of specific questions: whether my still-low iron stores after three months of oral supplementation justified an IV iron infusion; whether cortisol excess, Mounjaro, or both might be suppressing my stomach acid enough to explain that and other absorption problems; whether that was worth formally testing; whether my B12, folate, and homocysteine numbers pointed to a malabsorption picture rather than a dietary one; whether a Cushing’s diagnosis that’s likely been sitting there for years changes anything about my colon polyp surveillance interval; and whether SIBO was worth investigating now or better deferred. I even left blank lines under each question for the PA to write answers on, so nothing would get lost between the appointment and my memory of it afterward.

I’m not printing that whole document here — it’s dense, it’s clinical, and most of you didn’t come here for a lab-value deep dive. But I’ll tell you how the visit actually went: the PA moved fast, redirected or waved off a real chunk of what I’d written down, and ordered a set of tests without walking me through why those five and not the others I’d specifically asked about. I left more frustrated than informed, which is exactly the outcome all that preparation was supposed to prevent.

To be fair to the PA, and to this whole series’ running theme: I don’t think what happened on September 9th was any one person being careless. It’s the same fifteen-minute-per-patient structure Chapter 1 was about, now showing up in a different specialty. A patient walks in with a six-page prepared list, and the system built around that appointment slot has no real mechanism for absorbing it. That’s not a defense of how it felt in the room. It’s just consistent with everything else this series has been documenting — and if you want the longer explanation of why that structure exists in the first place, I wrote about it on this site: “Your Doctor Didn’t Choose Fifteen Minutes. Their Employer Did.” It walks through the prior-authorization numbers, the RVU productivity quotas doctors are held to, and the corporate ownership incentives sitting underneath all of it.

What got ordered, and what I had to go learn on my own

Here’s what came out of that visit: a Liver Function Panel, a chronic hepatitis panel, a Celiac antibody profile, a Hemochromatosis gene test, and a C-Reactive Protein test. Nobody walked me through what any of them actually check for or why they were the right five, so I went and found out myself.

Liver Function Panel (LFP). A group of blood markers — enzymes like ALT and AST, plus things like bilirubin and albumin — that reflect how well the liver is functioning and whether it’s under stress. This is likely tied to two things in my case: an ALT elevation I’ve noticed that tracks with taking aspirin and normalizes when I stop it, and the Fibroscan I have scheduled for October 16th, which measures liver stiffness and fat content directly. A baseline liver panel ahead of that scan is a reasonable, standard step.

Chronic Hepatitis panel. Blood tests screening for hepatitis B and C — viral infections that can cause long-term liver inflammation and damage. This is a standard part of ruling causes in or out whenever a liver workup is underway, regardless of how likely any single cause seems.

Celiac antibody profile (tTG-IgA, DGP IgG/IgA, total IgA). Celiac disease is an autoimmune reaction to gluten that damages the lining of the small intestine, which is exactly where much of nutrient absorption happens — including iron, B12, and folate. The “total IgA” part matters because a subset of people don’t produce much IgA at all, which would make the main antibody test read falsely negative; testing total IgA alongside it is how labs catch that. Given everything I’d written in my own briefing about unexplained iron and B-vitamin issues, this is actually one of the more directly relevant tests they ordered — I just wish someone had told me that connection out loud instead of me having to reconstruct it after the fact.

Hemochromatosis gene test (HFE). This one initially confused me, because hemochromatosis is a genetic condition that causes the body to absorb and store too much iron — the opposite of the deficiency I’ve actually been dealing with. My best understanding is that it’s a standard inclusion whenever a liver and iron-metabolism workup is being run together, since it’s a common enough hereditary cause of liver problems that it gets ruled out as a matter of course rather than because anyone suspects it specifically applies to me.

C-Reactive Protein (CRP). A general marker of inflammation somewhere in the body. It doesn’t point to a specific cause on its own, but it’s a cheap, common way to get a broad read on whether something inflammatory is going on that more targeted tests should chase down.

What’s notably absent from that list: IV iron approval or a referral for one, any gastric acid testing, an MMA test to check my B12 status at the functional level rather than just the raw serum number, RBC folate, a homocysteine retest, any real discussion of the colon polyp surveillance question, and any real answer on SIBO. Those were five of my seven prepared sections. I’m not asserting any of that was medically wrong to skip — I’m not qualified to make that call, and it’s entirely possible some of it gets addressed once the current round of results is in. I’m noting it because I wrote it down in advance specifically so it wouldn’t be lost, and it mostly got lost anyway.

A brief non-negotiable note, same as every chapter: none of this is medical advice, mine or yours. I’m not diagnosing my own labs in public, and I’m not suggesting anyone else self-manage theirs off what I write here. I’m describing what the tests are for in plain language, in the general sense any patient is entitled to have explained to them — the specific relevance to my case is a conversation for my actual doctors, several of whom I’m lucky enough to have.

Results pending, and a calendar filling up fast

In the meantime, October is shaping up to be the busiest month of this whole process:

  • September 17th — a full abdomen scan, which should give a clearer structural picture beyond what the original adrenal-focused imaging showed.
  • October 16th — the Fibroscan, checking liver stiffness and fat content directly, presumably informed by whatever the Liver Function Panel and hepatitis results show between now and then.
  • October 26th — adrenal vein sampling (AVS), the procedure Chapter 2 ended on. This is the one that actually determines the path forward: which gland, if either individually, is driving the excess cortisol, and whether surgery on one side, medication, or something else is the right next move.

Three procedures, three different specialists’ domains, six weeks apart, and as of today, I’m the only person who’s looking at all three on one calendar at the same time.

A Google review, and a suspiciously-timed voicemail

The very next day after the appointment, the office sent the standard follow-up: a link to leave a Google review. I left one, and I didn’t soften it — I wrote what actually happened, in roughly the same terms I’ve used here. The practice replied to the review fairly quickly, asking me to contact the office directly to discuss it. I haven’t taken them up on that, and for now I don’t plan to. I’m leaving the review exactly where it is and watching to see whether it comes up on any future visit — a small, unscientific test of whether a written record actually changes how a system responds, which feels appropriate given what this whole series is about.

Then, at almost the same time, I got a voicemail: the PA had spoken with Dr. Levitan directly, and the doctor was now recommending an upper endoscopy — an EGD — ahead of my follow-up visit. I want to be honest about where my mind went next, because I think it’s a fair question rather than a paranoid one: did that recommendation come from someone taking a genuine second look at my chart, or did it come from a critical review landing in an inbox at the same time? I don’t have enough information to answer that, and I’m not going to pretend I do. Both are entirely plausible. I’m noting the timing here, not accusing anyone of anything.

The same thread, a different room

I said in Chapter 1 that the structural problem underneath my own story isn’t unique to me, and I meant it broadly — not just about the endocrine system, and not just about the specific doctors who happened to be in the room. Fifteen-minute visits and single-specialty silos don’t stop being a problem just because the specialty changes. I brought a written, organized, six-page document specifically designed to withstand a rushed appointment, and it still didn’t fully survive it. That’s not really a story about one PA having a bad day. It’s the same story as Chapter 1, just with a different name on the door.

Chapter 4 is whenever the abdomen scan, the pending labs, the Fibroscan, or a callback about that EGD gives me something worth writing about — whichever comes first.